AUS
NZ
UK
CA
USA
IND
Healthcare
Vertex Pharmaceuticals (NASDAQ:VRTX) Gains Focus on CASGEVY Expansion
July 02, 2026 03:29 PM AEST| By Anmol KhazanchiVertex Pharmaceuticals NASDAQ:VRTX operates in healthcare sector of S&P 500, where CASGEVY expansion reflects genetic medicine progress and rare disease treatment developments across clinical systems.
Can Pfizer (NYSE:PFE) Advance Its Next-Generation Oncology Pipeline?
July 02, 2026 04:17 AM AEST| By Anmol KhazanchiCancer research updates keep a major pharmaceutical name in focus as oncology development, clinical progress, and healthcare innovation shape sector attention and business positioning.
Why Is Eli Lilly (NYSE:LLY) Obesity Pill In Focus?
July 02, 2026 04:14 AM AEST| By Anmol KhazanchiEli Lilly’s oral obesity treatment expansion keeps metabolic care and healthcare access strategy in focus.
Decoy Therapeutics (NASDAQ:DCOY) Jumps 6% Today on New Financing
July 01, 2026 10:30 AM PDT| By Nitish Kishor• DCOY shares rose 6.40% intraday to $7.65.
UnitedHealth Group (NYSE:UNH) Faces Medicare Reset
July 02, 2026 04:04 AM AEST| By Anmol KhazanchiMedicare Advantage changes, reimbursement pressure, and healthcare cost trends are shaping a major managed care company’s strategy as it reassesses coverage markets and operational priorities.
Syndax Pharmaceuticals (NASDAQ:SNDX) Draws Fresh Market Attention
July 02, 2026 02:08 AM AEST| By Anmol KhazanchiSyndax Pharmaceuticals remains in focus as oncology pipeline progress, financial discipline, and market sentiment shape attention around its position in the biotechnology healthcare space.
Bruker (NASDAQ:BRKR) Sparks Fresh Lab Tech Buzz
July 02, 2026 02:04 AM AEST| By Anmol KhazanchiScientific instruments remain in focus as stronger earnings, dividend continuity, and laboratory technology demand shape market attention around advanced research equipment and healthcare innovation.
Evommune (NYSE:EVMN) Slips Today After EVO756 Trial Misses Primary Endpoint
July 01, 2026 10:30 AM PDT| By Nitish Kishor• EVMN shares fell 1.39% intraday to $13.11 after the company reported Phase 2b trial results for EVO756.
Is Nuvation Bio (NYSE:NUVB) Building A Global Cancer Franchise?
July 02, 2026 12:27 AM AEST| By Anmol KhazanchiNuvation Bio continues expanding its global oncology strategy through regulatory progress, pipeline development, and international commercialization efforts.
Guardian Pharmacy (NYSE:GRDN) Joins Russell 2000 Defensive Indices
July 01, 2026 03:56 PM AEST| By Anmol KhazanchiGuardian Pharmacy Services continues expanding long-term care pharmacy operations while NYSE Composite healthcare presence includes regional pharmacy networks, medication management, clinical consultation, and pharmaceutical services.
Becton Dickinson (NYSE:BDX) Advances in NYSE Composite After Vizient Deal
July 01, 2026 03:29 PM AEST| By Anmol KhazanchiBecton Dickinson advanced medical technology initiatives, expanded product developments, and maintained a strong healthcare presence within the NYSE Composite Index through diversified global operations.
Beta Bionics (NASDAQ:BBNX) Rises 4% Today Despite Securities Investigation
July 01, 2026 10:29 AM PDT| By Nitish Kishor• BBNX shares rose 4.36% intraday to $16.35.
Oscar Health (NYSE:OSCR) Slips on Revenue Miss in NYSE Composite
July 01, 2026 02:04 PM AEST| By Anmol KhazanchiExplore Oscar Health business operations, quarterly revenue developments, digital healthcare services, ACA marketplace presence, and healthcare sector activity connected with the NYSE Composite today.
Johnson (NYSE:JNJ) Cancer Drug Progress Sparks Fresh Focus
July 01, 2026 01:41 AM AEST| By Anmol KhazanchiOncology progress, a sharper healthcare structure, and MedTech strength are shaping the latest market debate, while litigation exposure and pipeline execution remain important watch points
Bruker (NASDAQ:BRKR) Clears A Key Market Test
July 01, 2026 01:26 AM AEST| By Anmol KhazanchiBruker’s move above a key average renewed focus on technical momentum, quarterly performance, valuation, and demand across scientific instrument markets.
Modular Medical (NASDAQ:MODD) Rises 3% Today on FDA Software Submission
July 01, 2026 10:09 AM PDT| By Nitish Kishor• MODD shares rose 3.33% intraday to $4.65.
OmniAb (NASDAQ:OABI) Cash Burn Looks Manageable
July 01, 2026 12:43 AM AEST| By Anmol KhazanchiOmniAb’s cash burn appears manageable as its debt-free balance sheet, improved spending discipline, and platform revenue progress support a measured financial outlook.
GSK plc (NYSE:GSK) Strengthens Healthcare Focus With Antibiotic Progress
June 30, 2026 08:43 PM AEST| By Anmol KhazanchiGSK plc gained attention after regulatory progress for an oral antibiotic strengthened its anti-infective position and reinforced its broader role across pharmaceutical healthcare innovation.
Pfizer Inc (NYSE:PFE) Reshapes Healthcare Pipeline Through Dealmaking
June 30, 2026 08:38 PM AEST| By Anmol KhazanchiPfizer Inc remains in focus as pipeline expansion, metabolic medicine activity, oncology progress and regulatory developments shape its position within the broader pharmaceutical and healthcare sector.
Nuvectis Pharma (NASDAQ:NVCT) Rises 4% Today as $100 Million Offering Closes
July 01, 2026 10:09 AM PDT| By Nitish Kishor• NVCT shares rose 4.05% intraday to $19.14 on volume nearly four times the daily average.
Eli Lilly And Company (NYSE:LLY) Advances Metabolic Medicine Frontier
June 30, 2026 08:33 PM AEST| By Anmol KhazanchiEli Lilly and Company remains in focus as metabolic medicine advances, oral therapy progress, and healthcare innovation continue shaping attention across the pharmaceutical sector.
UnitedHealth Group (NYSE:UNH) Rides Healthcare Surge
June 30, 2026 04:41 AM AEST| By Anmol KhazanchiUnitedHealth Group gains focus as healthcare strength and managed-care demand shape market sentiment.
Merck (NYSE:MRK) Draws Heat As Healthcare Surges
June 30, 2026 04:29 AM AEST| By Anmol KhazanchiHealthcare strength, defensive demand, and renewed pharma activity are keeping major drugmakers in focus as market attention shifts toward steadier business models.
Mobile-health Network Solutions (NASDAQ:MNDR) Gains 2% Today as Reverse Split Takes Effect
July 01, 2026 10:07 AM PDT| By Nitish Kishor• MNDR shares rose 2.00% intraday to $3.12 as its reverse stock split took effect.
How Is Eli Lilly (NYSE:LLY) Positioned As Healthcare Hits Record Highs?
June 30, 2026 04:25 AM AEST| By Anmol KhazanchiHealthcare strength has placed major pharma names in focus as defensive demand, sector rotation, and medicine development continue shaping attention across the broader market.
Why Is Teladoc Health Stock In Focus (NYSE:TDOC)
June 30, 2026 02:46 AM AEST| By Team Kalkine MediaTeladoc Health attracts attention through virtual healthcare expansion, Russell index developments, technology innovation, and growing demand for digital medical services across healthcare.
